Provider-Guided Weight Loss Programs • Secure Online Assessment
You have %itemCount% in your cart. Total being %total%
Explore whether provider-guided semaglutide injection or another medical weight-management option may be appropriate for you through a convenient online assessment.
Provider review required. Eligibility, treatment, medication and results are not guaranteed.
Persistent hunger, cravings, reduced fullness, metabolic factors and weight regain can make progress feel harder than it should. For eligible adults, provider-guided treatment may offer another approach built around medical history, goals and clinical suitability.
Semaglutide works with GLP-1 pathways involved in appetite, fullness, digestion, blood-sugar response and metabolic function. Treatment is considered only after individual medical review.
Semaglutide works with the GLP-1 pathway involved in appetite regulation, fullness, digestion and metabolic response.
When prescribed, treatment is administered as a subcutaneous injection according to provider instructions.
Begin from home through a streamlined health assessment and licensed provider-review process.
Answer questions about your health history, medications, goals and previous weight-management efforts.
A licensed healthcare provider evaluates your submitted information and clinical suitability.
If medically appropriate, your provider may recommend semaglutide injection, another option or no prescription treatment.
Completing the assessment does not guarantee eligibility or a prescription.
Program availability, medication, final pricing and included services depend on provider review and the option selected.
A short assessment can help a licensed provider determine whether semaglutide injection or another medical weight-management option may be worth considering.
The assessment is designed to take about three minutes for many users, although completion time may vary.
Completing the assessment allows a licensed provider to review your information. It does not guarantee or require treatment.
No. Your provider may recommend semaglutide injection, another option, request more information or determine that prescription treatment is not appropriate.
Semaglutide is administered as a subcutaneous injection according to product labeling and provider instructions. The specific product, schedule and dose depend on the treatment prescribed.
Semaglutide works with the GLP-1 pathway, while tirzepatide works with GLP-1 and GIP pathways. A licensed provider should determine which option, if any, may be appropriate for you.
FDA-approved branded semaglutide products exist for specific indications. Compounded semaglutide is not FDA-approved and is not the same as an FDA-approved branded or generic drug. Your treatment information should identify the specific product being considered.
Yes. Semaglutide and other prescription treatments may cause side effects and are not appropriate for everyone. Review warnings, contraindications, risks and medication interactions with your provider.
No. Treatment experiences and weight-management results vary by individual.
Complete the secure DietsMD assessment so a licensed healthcare provider can review your information and determine what options may be medically appropriate.
Provider review required. Treatment, medication, prescriptions and results are not guaranteed.
.dmd-article { font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif; color: #4a5568; max-width: 800px; margin...
With dozens of online weight loss programs available, knowing what to compare can help you make a more informed decision. This guide cove...
Semaglutide and tirzepatide both produce significant weight loss — but which GLP-1 is right for you? A physician breaks down the key diff...
